Sarcopenia following maximal androgen suppression in men with prostate cancer
Not Applicable
- Conditions
- prostate cancer
- Registration Number
- JPRN-UMIN000016175
- Lead Sponsor
- Yamaguchi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1.prostate cancer patient without any metastasis 2. Patient with a severe renal or liver function disorder 3. Patient with double cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of muscle mass, strength and function in temporal observation
- Secondary Outcome Measures
Name Time Method